Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 16, 2023 - Issue
Submit an article Journal homepage
361
Views
5
CrossRef citations to date
0
Altmetric
REVIEW

The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus

Meiyuan Dong1 Graduate School of Hebei Medical University, Shijiazhuang, People’s Republic of China;2 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2897-9316View further author information
ORCID Icon,
Huiling Chen2 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Song Wen2 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0001-6173-0507View further author information
ORCID Icon,
Yue Yuan2 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Liling Yang2 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
,
Dongxiang Xu2 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of ChinaView further author information
&
Ligang Zhou1 Graduate School of Hebei Medical University, Shijiazhuang, People’s Republic of China;2 Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of China;3 Shanghai Key Laboratory of Vascular Lesions Regulation and Remodeling, Shanghai Pudong Hospital, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 437-445 | Received 27 Nov 2022, Accepted 08 Feb 2023, Published online: 14 Feb 2023

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ru Li, Baofeng Wu, Minmin Han, Mengnan Li, Xifeng Yang, Jian Zhang, Yi Zhang & Yunfeng Liu. (2024) Uric Acid Metabolic Disorders in Pituitary-Target Gland Axis. Diabetes, Metabolic Syndrome and Obesity 17, pages 661-673.
Read now

Articles from other publishers (4)

Simo Liu, Jing Ke, Xiaotong Feng, Zongwei Wang, Xin Wang, Longyan Yang & Dong Zhao. (2024) The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus. Journal of Diabetes Research 2024, pages 1-7.
Crossref
S. Amalraj, J. Krupa, C. David Raj, S.S. Gurav, G. Rajiv Gandhi & M. Ayyanar. (2024) Antidiabetic and antioxidant activities of the hydroalcoholic extracts of Canthium coromandelicum (Burm.f.) Alston leaf in Streptozotocin-induced diabetic rats. Process Biochemistry 137, pages 85-98.
Crossref
Jia Liu, Xiaona Chang, Xiaoyu Ding, Xueqing He, Jiaxuan Wang & Guang Wang. (2023) Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes. Diabetology & Metabolic Syndrome 15:1.
Crossref
Arianna Maiorana, Francesco Tagliaferri & Carlo Dionisi-Vici. (2023) Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders. Frontiers in Endocrinology 14.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.